Fampyra has been given the green light for use by the Health Service in Scotland to treat people with MS who have a walking disability. Approval was given by the Scottish Medicine Consortium) despite a known increased risk of seizures.
Fampyra has been given the green light for use by the Health Service in Scotland to treat people with MS who have a walking disability. Approval was given by the Scottish Medicine Consortium) despite a known increased risk of seizures.
